Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials (Q41115235)

26 September 2017

0 references

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials (English)

1 reference

26 September 2017

1 reference

myocardial infarction

1 reference

1 reference

Collins R

1

1 reference

26 September 2017

MacMahon S

2

1 reference

26 September 2017

Flather M

3

1 reference

26 September 2017

Baigent C

4

1 reference

26 September 2017

Remvig L

5

1 reference

26 September 2017

Mortensen S

6

1 reference

26 September 2017

Appleby P

7

1 reference

26 September 2017

Godwin J

8

1 reference

26 September 2017

Yusuf S

9

1 reference

26 September 2017

Peto R

10

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

26 September 2017

1 reference

26 September 2017

313

1 reference

26 September 2017

7058

1 reference

26 September 2017

652-659

1 reference

INITIAL HEPARIN THERAPY IN ACUTE MYOCARDIAL INFARCTION

26 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Current and future perspectives on antithrombotic therapy of acute myocardial infarction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Venous thromboses in myocardial infarction. Comparison in heparin dosage

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Long-term anticoagulant therapy after myocardial infarction.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

A double-blind trial of long-term anticoagulant treatment after myocardial infarction.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Anticoagulant treatment of acute coronary thrombosis.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Low-dose heparin after myocardial infarction.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Prophylactic anticoagulation for left ventricular thrombi after acute myocardial infarction: a prospective randomized trial

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Correlation between level of heparinization and patency of the infarct-related coronary artery after treatment of acute myocardial infarction with alteplase (rt-PA).

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

PREINFARCTION SYNDROME--MANAGEMENT AND FOLLOW-UP.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2351968

A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction

19 August 2018

1 reference

12 December 2020

Why do we need systematic overviews of randomized trials?

1 reference

12 December 2020

Anticoagulants in acute myocardial infarction. The failure of anticoagulants to alter mortality in a randomized series

1 reference

12 December 2020

A controlled trial of long-term treatment with anticoagulants after myocardial infarction in 412 male patients

1 reference

12 December 2020

Coronary occlusion treated with small doses of heparin

1 reference

12 December 2020

Heparin in the Prevention of Deep Vein Thrombosis after Myocardial Infarction

1 reference

12 December 2020

Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction

1 reference

12 December 2020

Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis

1 reference

12 December 2020

Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking

1 reference

12 December 2020

Low dose heparin in the prevention of deep-vein thromboses in patients with acute myocardial infarction

1 reference

12 December 2020

[Low-dose heparin therapy in the prevention of deep venous thrombosis in acute myocardial infarction. A controlled clinical trial]

1 reference

12 December 2020

Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction

1 reference

12 December 2020

[Value of early anticoagulation in the prevention of intraventricular thrombosis after a 1st myocardial infarction: prospective and randomized study]

1 reference

12 December 2020

Treatment of acute myocardial infarction with subcutaneous heparin at low doses

1 reference

12 December 2020

Low-dose heparin in the prevention of thrombotic complications following acute myocardial infarction

1 reference

12 December 2020

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

1 reference

12 December 2020

A Standard Heparin Nomogram for the Management of Heparin Therapy

1 reference

12 December 2020

Guide to anticoagulant therapy. Part 1: Heparin. American Heart Association

1 reference

12 December 2020

Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial

1 reference

12 December 2020

Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries

1 reference

12 December 2020

Overview of randomized trials of intravenous heparin in patients with acute myocardial infarction treated with thrombolytic therapy

1 reference

12 December 2020

The effect of long term treatment with dicoumarol in myocardial infarction; a controlled clinical study

1 reference

12 December 2020

Long-term anticoagulant therapy after myocardial infarction

1 reference

12 December 2020

Effect of early anticoagulation on the frequency of left ventricular thrombi after anterior wall acute myocardial infarction

1 reference

12 December 2020

Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction

1 reference

12 December 2020

[Prevention of deep venous thrombosis with low-dose heparin in patients with acute uncomplicated myocardial infarct: double-blind controlled study]

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.313.7058.652

1 reference

26 September 2017

1 reference

26 September 2017

1 reference